[Comparative evaluation of the clinical effectiveness of spasmolytic preparations in coronary arteriosclerosis].
D000628:Aminophylline / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy; D001593:Benzyl Compounds / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D004338:Drug Combinations; D005019:Ethyl Ethers / Q000627:therapeutic use; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D001593:Benzyl Compounds; D004338:Drug Combinations; D005019:Ethyl Ethers; D007546:Isoquinolines; D009539:Nicotinic Acids; D010276:Parasympatholytics; D014665:Vasodilator Agents; D000628:Aminophylline
Sravnitel'naia otsenka klinicheskoĭ éffektivnosti spazmoliticheskikh preparatov u bol'nykh koronarnym aterosklerozom.